Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer
- 16 August 2023
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 260 (5) , 621-636
Abstract
Tumour heterogeneity is pervasive amongst many cancers and leads to disease progression, and therapy resistance. In this review, using breast cancer as an exemplar, we focus on the recent advances in understanding the interplay between tumour cells and their microenvironment using single cell sequencing and digital spatial profiling technologies. Further, we discuss the utility of lineage tracing methodologies in pre‐clinical models of breast cancer, and how these are being used to unravel new therapeutic vulnerabilities and reveal biomarkers of breast cancer progression. © 2023 The Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- Breast Cancer Now
This publication has 175 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cellsNature Biotechnology, 2012
- The landscape of cancer genes and mutational processes in breast cancerNature, 2012
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- The Life History of 21 Breast CancersCell, 2012
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- Linking promoters to functional transcripts in small samples with nanoCAGE and CAGEscanNature Methods, 2010
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- mRNA-Seq whole-transcriptome analysis of a single cellNature Methods, 2009
- Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastasesBreast Cancer Research and Treatment, 2006